Oxford Performance Materials (OPM) has announced an agreement with Fuse Medical to develop new, spinal, extremity and sports medicine implant product lines utilising the former’s patented OsteoFab polyetherketoneketone (PEKK) technology.
The agreement between the companies enables Fuse to develop new cervical and lumbar spinal interbodies, soft tissue fixation devices for sports medicine, as well as other foot and ankle implants featuring OPM’s proprietary 3D printing intellectual property, which the OPM says delivers clinical benefits to surgeons such as bone like mechanics, bone ongrowth, radiolucency, and antibacterial and antiviral properties.
Scott DeFelice, OPM founder and CEO, said: “As OPM focuses on providing advanced implantable polymers and contract manufacturing services, we look to work with industry leaders that are dedicated to innovative solutions that drive medical device technology forward in ways that reduce system costs and improve patient outcomes. Fuse clearly fits this mould, and we are extremely pleased to be making this important partnership announcement.”
Fuse CEO, Chris Reeg, added, “This new collaboration with OPM continues our mission to develop unique, differentiated products and technologies with breakout potential. Over the past year, Fuse has developed a deep scientific understanding of OPM’s OsteoFab PEKK technology, and our team is extremely excited about developing new product lines in spine, sports medicine, and foot and ankle that feature OsteoFab’s unique set of clinical benefits.”